Lily Wu

Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles

Affiliated withDavid Geffen School of Medicine, University of California, Los Angeles University of California Los Angeles

Research Area

Cancer Research

Biography

Lily Wu has not added Biography.
If you are Lily Wu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 9	2020
Publication title Cited by 13	2020

Other Publications

Article	Year
Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. Human gene therapy\| PubMed ID: 11975845	2002
Interrogating androgen receptor function in recurrent prostate cancer. Cancer research\| PubMed ID: 12907631	2003
Integrated, molecular engineering approaches to develop prostate cancer gene therapy. Current gene therapy\| PubMed ID: 14529351	2003
Transcriptionally targeted gene therapy to detect and treat cancer. Trends in molecular medicine\| PubMed ID: 14557054	2003
Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach. Molecular imaging\| PubMed ID: 16285908	2005
Applications of molecular imaging in cancer gene therapy. Current gene therapy\| PubMed ID: 16457650	2005
Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Human gene therapy\| PubMed ID: 17117891	2006
The current state of preclinical prostate cancer animal models. The Prostate\| PubMed ID: 18213636	2008
Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nature medicine\| PubMed ID: 18622403	2008
Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer research\| PubMed ID: 18829538	2008
Non-invasive molecular imaging of prostate cancer lymph node metastasis. Trends in molecular medicine\| PubMed ID: 19482514	2009
Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line. Molecular cancer research : MCR\| PubMed ID: 19723877	2009
Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 19926832	2010
Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines. The Prostate\| PubMed ID: 20087897	2010
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels. Molecular genetics and metabolism\| PubMed ID: 20619710	2010
Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer. Cancer research\| PubMed ID: 21933883	2011
Chapter five--The development of transcription-regulated adenoviral vectors with high cancer-selective imaging capabilities. Advances in cancer research\| PubMed ID: 23021244	2012
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer. Cancer research\| PubMed ID: 23418320	2013
Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer research\| PubMed ID: 24247719	2014
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer research\| PubMed ID: 25736687	2015
Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer. Cancer research\| PubMed ID: 26471360	2015
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer. Oncotarget\| PubMed ID: 26594800	2016
Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression. The Prostate\| PubMed ID: 27338236	2016
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 27879367	2017
Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells. Stem cell reports\| PubMed ID: 28793246	2017
Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc\| PubMed ID: 29076496	2018
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer. Endocrine-related cancer\| PubMed ID: 30400004	2019
Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma. The Enzymes\| PubMed ID: 31727277	2019